ATE229981T1 - Glykolisierte cytokine - Google Patents
Glykolisierte cytokineInfo
- Publication number
- ATE229981T1 ATE229981T1 AT93115060T AT93115060T ATE229981T1 AT E229981 T1 ATE229981 T1 AT E229981T1 AT 93115060 T AT93115060 T AT 93115060T AT 93115060 T AT93115060 T AT 93115060T AT E229981 T1 ATE229981 T1 AT E229981T1
- Authority
- AT
- Austria
- Prior art keywords
- cytokine
- glycolized
- liver
- sugar
- dose
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25496292 | 1992-09-24 | ||
JP8892093 | 1993-04-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE229981T1 true ATE229981T1 (de) | 2003-01-15 |
Family
ID=26430256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93115060T ATE229981T1 (de) | 1992-09-24 | 1993-09-18 | Glykolisierte cytokine |
Country Status (9)
Country | Link |
---|---|
US (1) | US5643564A (de) |
EP (1) | EP0589378B1 (de) |
KR (1) | KR940007058A (de) |
CN (1) | CN1087916A (de) |
AT (1) | ATE229981T1 (de) |
CA (1) | CA2106821A1 (de) |
DE (1) | DE69332576T2 (de) |
PH (1) | PH31582A (de) |
TW (1) | TW263437B (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0770195A (ja) * | 1993-08-23 | 1995-03-14 | Yutaka Mizushima | 糖修飾インターフェロン |
IL116730A0 (en) * | 1995-01-13 | 1996-05-14 | Amgen Inc | Chemically modified interferon |
DE69636112T2 (de) * | 1995-08-30 | 2006-12-14 | Toray Industries, Inc. | Verfahren zum testen von myocarditis und cardiomyopathie |
AUPP660698A0 (en) * | 1998-10-21 | 1998-11-12 | University Of Queensland, The | A method of protein engineering |
AR078117A1 (es) | 2006-06-20 | 2011-10-19 | Protech Pharma S A | Una muteina recombinante del interferon alfa humano glicosilado, un gen que codifica para dicha muteina, un metodo de produccion de dicho gen, un metodo para obtener una celula eucariota productora de dicha muteina, un metodo para producir dicha muteina, un procedimiento para purificar dicha muteina |
BR112013022170B1 (pt) * | 2011-03-02 | 2022-05-24 | Sensulin, Llc | Composições de vesícula |
AU2018300069A1 (en) | 2017-07-11 | 2020-02-27 | Synthorx, Inc. | Incorporation of unnatural nucleotides and methods thereof |
WO2019028425A1 (en) | 2017-08-03 | 2019-02-07 | Synthorx, Inc. | CONJUGATES OF CYTOKINE FOR THE TREATMENT OF AUTOIMMUNE DISEASES |
MX2021009259A (es) | 2019-02-06 | 2021-08-24 | Synthorx Inc | Conjugados de il-2 y metodos de uso del mismo. |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4386026A (en) * | 1981-04-20 | 1983-05-31 | Merck & Co., Inc. | Cell-specific glycopeptide ligands |
US4609546A (en) * | 1982-06-24 | 1986-09-02 | Japan Chemical Research Co., Ltd. | Long-acting composition |
JP2514950B2 (ja) * | 1986-03-10 | 1996-07-10 | エフ・ホフマン―ラ ロシユ アーゲー | 化学修飾蛋白質,その製造法および中間体 |
JPS63152393A (ja) * | 1986-07-03 | 1988-06-24 | Takeda Chem Ind Ltd | グリコシル誘導体 |
HU906340D0 (en) * | 1986-10-13 | 1991-04-29 | Sandoz Ag | Synthesis in solid phase for producing peptonic alcohols |
US5162503A (en) * | 1987-05-19 | 1992-11-10 | Hoffmann-La Roche, Inc. | Purification of interleukin-2 by receptor-affinity chromatography |
US4829690A (en) * | 1987-06-26 | 1989-05-16 | Andros Theodore A | Credit card chain holder |
JPH01102098A (ja) * | 1987-10-14 | 1989-04-19 | Toray Ind Inc | 糖鎖修飾糖タンパク質 |
JPH01102099A (ja) * | 1987-10-14 | 1989-04-19 | Toray Ind Inc | 生理活性を有する糖タンパク質 |
US4902502A (en) * | 1989-01-23 | 1990-02-20 | Cetus Corporation | Preparation of a polymer/interleukin-2 conjugate |
JPH03106900A (ja) * | 1989-09-20 | 1991-05-07 | Toray Ind Inc | 糖鎖修飾ヒトインターフェロン集合体 |
JPH085914B2 (ja) * | 1990-02-16 | 1996-01-24 | 株式会社ディ・ディ・エス研究所 | グリコシル−蛋白誘導体 |
US5096816A (en) * | 1990-06-05 | 1992-03-17 | Cetus Corporation | In vitro management of ammonia's effect on glycosylation of cell products through pH control |
JPH0770195A (ja) * | 1993-08-23 | 1995-03-14 | Yutaka Mizushima | 糖修飾インターフェロン |
-
1993
- 1993-09-14 TW TW082107513A patent/TW263437B/zh active
- 1993-09-18 AT AT93115060T patent/ATE229981T1/de not_active IP Right Cessation
- 1993-09-18 DE DE69332576T patent/DE69332576T2/de not_active Expired - Fee Related
- 1993-09-18 EP EP93115060A patent/EP0589378B1/de not_active Expired - Lifetime
- 1993-09-23 CA CA002106821A patent/CA2106821A1/en not_active Abandoned
- 1993-09-23 PH PH46943A patent/PH31582A/en unknown
- 1993-09-23 CN CN93117879A patent/CN1087916A/zh active Pending
- 1993-09-24 KR KR1019930019661A patent/KR940007058A/ko not_active Application Discontinuation
-
1995
- 1995-05-31 US US08/455,661 patent/US5643564A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0589378A3 (de) | 1995-02-22 |
TW263437B (de) | 1995-11-21 |
DE69332576D1 (de) | 2003-01-30 |
DE69332576T2 (de) | 2003-11-20 |
EP0589378B1 (de) | 2002-12-18 |
CA2106821A1 (en) | 1994-03-25 |
KR940007058A (ko) | 1994-04-26 |
EP0589378A2 (de) | 1994-03-30 |
CN1087916A (zh) | 1994-06-15 |
PH31582A (en) | 1998-11-03 |
US5643564A (en) | 1997-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO306377B1 (no) | Doseform for avgivelse av et medikament | |
GR3022060T3 (en) | Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication | |
ATE316792T1 (de) | Stimulierung wirtseigener abwehrmechanismen gegen krebs | |
DK0911033T3 (da) | Anvendelse af konsensusinterferon til reduktion af bivirkningerne af interferonbehandling i viral hepatitis | |
HK25395A (en) | Low dosage of interferon to enhance vaccine efficiency | |
DE69231062D1 (de) | Morphogen-induzierte Modulation von entzündlichen Antworten | |
DE68914644D1 (de) | Verringerung der nebeneffekte bei der krebstherapie. | |
ATE229981T1 (de) | Glykolisierte cytokine | |
DE3851456T2 (de) | Synergetische immunostimulierende Zusammensetzung und ihre Verwendung. | |
ITRM920693A1 (it) | Impiego di l-carnitina e acil l-carnitine nel trattamento di pazienti affetti da aids e sindromi correlate e di pazienti asintomatici hivsieropositivi. | |
ZA912037B (en) | Use of il-4 to enhance immune response to infectious antigenic challenges | |
KR900009029A (ko) | 가축병 치료용 약물을 투여하는 장치 | |
ES2160927T3 (es) | Composiciones farmaceuticas que comprenden interferon alfa humano natural. | |
ES2042864T3 (es) | Empleo y agente para reducir los efectos secundarios de tnf. | |
IT1210305B (it) | Massaggiatore per corpo umano | |
IT1172271B (it) | Dispositivo per il trattamento combinato terapeutico e stimolante delle gengive | |
IT1246050B (it) | Impiego dell'eptastigmina nella terapia dell'ictus cerebrale. | |
IT9021051A0 (it) | "procedimento di estrzione e purificazione del gamma interferone umano ricombite" | |
DK0427633T3 (da) | Anvendelse af et polypeptid med gammainterferonaktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af primitiv pleuracancer | |
RU93027571A (ru) | Способ усиления противоопухолевого эффекта лучевой терапии | |
ITTO920519A0 (it) | Sussidio terapeuticodinamico per larieducazione sensitivo-motoria del-l'arto superiore in pazienti cerebrolesi. | |
ITMO910042A1 (it) | Vibromassaggiatore per massaggiare il corpo umano. | |
ZA914219B (en) | Transdermal administration to humans and animals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |